Cancer Immunotherapy Trials Network 12: Pembrolizumab in HIV-Associated Kaposi Sarcoma is a research paper published in Journal of Clinical Oncology (2024). On theSindex it has a DataRank of 0.592. It has been cited 22 times, with 17 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.470
From this paper's citation signal
Citation Network Contribution
0.122
From 6 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 17 citers.
NCI NIH HHS
Grant: UM1 CA154967
NCI NIH HHS
Grant: 75N91019D00024
NCI NIH HHS
Grant: HHSN261201500003C
Intramural NIH HHS
Grant: Z99 CA999999
NCI NIH HHS
Grant: U01 CA154967
NCI NIH HHS
Grant: HHSN261201500003I
FWCI
4.02
Citation Percentile
1.0%
Influential Citations
1
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals